Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis

Translational Research

Volumn 150, Issue 2, 2007, Pages 101-105

  Buraczynska, Monika ^a   Jozwiak, Lucyna ^a   Ksiazek, Piotr ^a   Borowicz, Ewa ^a   Mierzicki, Piotr ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; CHOLESTEROL; CREATININE; INTERLEUKIN 6; RESTRICTION ENDONUCLEASE;

ADULT; ALLELE; ARTICLE; CELL TYPE; CHRONIC GLOMERULONEPHRITIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; IMMUNOREGULATION; KIDNEY FAILURE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MESANGIUM CELL; MONOCYTE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 34447515457     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.03.003     Document Type: Article

References (27)

1. Galla J.H. Molecular genetics in IgA nephropathy. Nephron 88 (2001) 107-112
2. Eitner F., and Floege J. Novel insights into renal fibrosis. Current Opin Nephrol Hypertens 12 (2003) 227-232
3. Chow K.M., Wong T.Y., and Li P.K. Genetics of common progressive renal disease. Kidney Int 67 suppl 94 (2005) S41-S45
4. Padiyar A., and Sedor J.A. Genetic and genomic approaches to glomerulosclerosis. Curr Mol Med 5 (2005) 497-507
5. Hirano T., Akira S., Taga T., and Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today 11 (1990) 443-449
6. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 8 (1990) 253-278
7. Coleman D.L., and Ruef C. Interleukin-6 : an autocrine regulator of mesangial cell growth. Kidney Int 41 (1992) 604-606
8. Kristiansen O.P., and Mandrup-Poulsen T. Interleukin-6 and diabetes. The good, the bad, or the indifferent. Diabetes 54 suppl 2 (2005) S114-S124
9. Horii Y., Iwano M., Hirata E., Shiiki M., Fujii Y., Dohi K., et al. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int 39 (1993) S71-S75
10. Hirano T. Interleukin-6 and its relation to inflammation and disease. Clin Immunol and Immunopathol 62 (1992) S60-S65
11. Bennermo M., Held C., Stemme S., Ericsson C.-G., Silveira A., Green F., et al. Genetic predisposition of the interleukin-6 response to inflammation. Clin Chemistry 50 (2004) 2136-2140
12. Kishimoto T. Interleukin-6 and its receptor in autoimmunity. J Autoimmun 5 (1992) 123-132
13. Acalovschi D., Wiest T., Hartmann M., Farahmi M., Mansmann U., Auffarth G.U., et al. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 34 (2003) 1864-1870
14. Akira S., Taga T., and Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 54 (1993) 1-78
15. Hirano T. Interleukin-6 and its receptor. Ten years later. Int Rev Immunol 16 (1998) 249-284
16. Terry C.F., Loukaci V., and Green F.R. Cooperative influence of genetic polymorphisms on interleukin-6 transcriptional regulation. J Biol Chem 275 (2000) 18138-18144
17. Bowcock A.M., Kidd J.R., Lathrop G.M., Danesvar L., May L.T., Ray A., et al. The human "interferon beta2 / hepatocyte stimulating factor / interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 3 (1988) 8-16
18. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376
19. Hulkkonen J., Petrovaara M., Antonen J., Pasternack A., and Hurme M. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL-6 gene in primary Sjorgen's syndrome and correlate within the clinical manifestations of the disease. Rheumatology 40 (2001) 656-661
20. Syrjänen J., Hurme M., Lehtimäki T., Mustonnen J., and Pasternack A. Polymorphism of the cytokine genes and IgA nephropathy. Kidney Int 67 (2002) 1079-1085
21. Bantis C., Heering P.J., Luther Y., Aker S., Kuhr N., Grabensee B., et al. Influence of cytokine gene polymorphisms on focal segmental glomerulosclerosis. Am J Nephrol 24 (2004) 427-431
22. Nakajima T., Ota N., Yoshida H., Watanabe S., Suzuki T., and Emi M. Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women. Genes Immun 1 (1999) 115-119
23. Kitamura A., Hasegawa E., Obayashi H., Kamiuchi K., Ishi M., Yano M., et al. Interleukin-6 polymorphism (-634 C/G) in the promoter region and the progression of diabetic nephropathy in type 2 diabetes. Diabet Med 19 (2002) 1000-1005
24. Gharavi A.G., Yan Y., Scolari F., Schena F., Frasc G.M., Ghiggeri E.M., et al. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 26 (2000) 354-357
25. Hsu S.I., Ramirez S.B., Win M., Bonventre J.V., and Owen W.F. Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int 57 (2000) 1818-1825
26. Yoon H.J., Shin J.H., Yang S.H., Chae D.W., Kim H., Lee D.S., et al. Association of the CD14 gene -159C polymorphism with progression of IgA nephropathy. J Med Genet 40 (2003) 104-108
27. Yoshioka K., Takemura T., Murakami K., Okada M., Yagi K., Miyazato H., et al. In situ expression of cytokines in IgA nephritis. Kidney Int 44 (1993) 825-833